Cellular Responses to Cancer Drug-Induced Genomic Breaks
Cellular Responses to Cancer Drug-Induced Genomic Breaks
批准号:
7169561
负责人:
TERRY A BEERMAN
金额:
$27.28万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-02-14 至 2009-01-31
关键词:
1-Phosphatidylinositol 3-KinaseAntineoplastic AgentsAtaxia-Telangiectasia-Mutated protein kinaseC 1027Cell Cycle CheckpointCell Cycle ProgressionCellsCharacteristicsChromosome abnormalityChromosomesChromosomes, Human, Pair 3ConditionCytogenetic AnalysisDNADNA DamageDNA Double Strand BreakDNA RepairDNA Repair PathwayDNA-Binding ProteinsDisruptionEnsureFluorescent in Situ HybridizationFunctional disorderGenetic RecombinationGenomicsImmunofluorescence MicroscopyInterphaseIonizing radiationKu ProteinMeasuresMetaphaseMitosisMitoticModelingNonhomologous DNA End JoiningOligonucleotidesPathway interactionsPharmaceutical PreparationsPhosphotransferasesPlayProcessPropertyProteinsRegulationRoleSpectral KaryotypingTandem Repeat SequencesTestingWestern Blottingantitumor drugcytotoxichomologous recombinationinsightrepairedresponsetelomere
中文摘要
描述(由申请人提供):细胞对电离辐射(IR)诱导的DNA双链断裂(DSBs)的反应包括通过磷脂酰肌醇3-激酶样激酶(PIKK) ATM激活细胞周期检查点蛋白,该蛋白延迟细胞周期进程,以允许DNA修复并保持染色体完整性。模拟辐射烯二炔C-1027诱导的DNA dsb反应与此模型不同。例如,IR诱导ATM依赖和C-1027 (ATM依赖和独立)响应。此外,使用等细胞毒性水平的IR或C-1027治疗,有丝分裂细胞显示异常染色体重组的百分比分别非常低(2.9%)或非常高(92%)。FISH分析显示,c -1027诱导的染色体畸变通常与端粒的破坏有关。
英文摘要
DESCRIPTION (provided by applicant): Cellular responses to ionizing radiation (IR)-induced DNA double strand breaks (DSBs) involve activation, via the phosphatidylinositol 3-kinase-like kinase (PIKK) ATM, of cell cycle checkpoint proteins that delay cell cycle progression to allow DNA repair and to preserve chromosomal integrity. Responses to DNA DSBs induced by the radiomimetic enediyne C-1027 deviate from this model. For example, IR induces ATM-dependent, and C-1027, both ATM- dependent and independent, responses. Furthermore, treatment with equi-cytotoxic levels of IR or C-1027 results in either a very low (2.9%), or an extraordinarily high (92%), percentage, respectively of mitotic cells showing aberrant chromosomal recombination. FISH analysis revealed that C-1027-induced chromosomal aberrations are frequently associated with disruption of telomeres.
The mechanism(s) behind these unique responses to the antitumor drug, C-1027 should help extend our understanding of DNA damage responses to DSBs. First, pivotal checkpoint pathway proteins involved in the response to C-1027 will be identified, with emphasis on both ATM-dependent and independent responses. Next the conditions under which C-1027 induces extensive chromosomal fusions, characterized by aberrant end-joining and fragmentation, will be identified. The NHEJ DNA binding protein Ku, which not only is involved in repair responses but also plays a role in regulating chromosomal fusions, will also be examined for its role in C-1027 induced aberrant end-joining. Finally, we will test whether C-1027, which induces DSBs preferentially within a GTTA motif, targets the telomere tandem repeat sequence (GGGTTA) and contributes to aberrant end-joining by inducing telomere dysfunction. Other enediynes with cleavage characteristics different from C-1027, will be tested selectively to provide additional mechanistic insights into which properties of C-1027-induced damage are associated with the DNA damage responses. The specific aims will test the following hypotheses:
1. C-1027 is unique compared to other enediynes and to IR in that it induces both ATM-dependent and independent DNA damage responses.
2. C-1027 is unique compared to other enediynes and to IR in that it causes extraordinarily high levels of rearranged chromosomes.
3. C-1027 is unique compared to other enediynes and IR in that it targets telomeres.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cellular Responses to Cancer Drug-Induced Genomic Breaks
-
批准号:6873124
-
项目类别:
-
资助金额:$28.03万
-
财政年份:2005
-
负责人:TERRY A BEERMAN
-
依托单位:
Cellular Responses to Cancer Drug-Induced Genomic Breaks
-
批准号:7018422
-
项目类别:
-
资助金额:$27.73万
-
财政年份:2005
-
负责人:TERRY A BEERMAN
-
依托单位:
Cellular Responses to Cancer Drug-Induced Genomic Breaks
-
批准号:7331469
-
项目类别:
-
资助金额:$27.65万
-
财政年份:2005
-
负责人:TERRY A BEERMAN
-
依托单位:
DNA MINOR GROOVE BINDING POLYAMIDES
-
批准号:6224834
-
项目类别:
-
资助金额:$31.88万
-
财政年份:2001
-
负责人:TERRY A BEERMAN
-
依托单位:
DNA MINOR GROOVE BINDING POLYAMIDES
-
批准号:6687292
-
项目类别:
-
资助金额:$33.34万
-
财政年份:2001
-
负责人:TERRY A BEERMAN
-
依托单位:
DNA MINOR GROOVE BINDING POLYAMIDES
-
批准号:6626692
-
项目类别:
-
资助金额:$32.79万
-
财政年份:2001
-
负责人:TERRY A BEERMAN
-
依托单位:
DNA MINOR GROOVE BINDING POLYAMIDES
-
批准号:6489294
-
项目类别:
-
资助金额:$32.33万
-
财政年份:2001
-
负责人:TERRY A BEERMAN
-
依托单位:
INHIBITION OF DNA REPLICATION BY DNA DAMAGING DRUGS
-
批准号:6150248
-
项目类别:
-
资助金额:$28.82万
-
财政年份:1998
-
负责人:TERRY A BEERMAN
-
依托单位:
INHIBITION OF DNA REPLICATION BY DNA DAMAGING DRUGS
-
批准号:2872013
-
项目类别:
-
资助金额:$27.98万
-
财政年份:1998
-
负责人:TERRY A BEERMAN
-
依托单位:
INHIBITION OF DNA REPLICATION BY DNA DAMAGING DRUGS
-
批准号:2595955
-
项目类别:
-
资助金额:$27.96万
-
财政年份:1998
-
负责人:TERRY A BEERMAN
-
依托单位:
INHIBITION OF DNA REPLICATION BY DNA DAMAGING DRUGS
-
批准号:6350281
-
项目类别:
-
资助金额:$29.68万
-
财政年份:1998
-
负责人:TERRY A BEERMAN
-
依托单位:
EXTRACHROMOSOMAL DNA--A NEW TARGET FOR ANTITUMOR DRUGS
-
批准号:2094916
-
项目类别:
-
资助金额:$11.61万
-
财政年份:1990
-
负责人:TERRY A BEERMAN
-
依托单位:
EXTRACHROMOSOMAL DNA--A NEW TARGET FOR ANTITUMOR DRUGS
-
批准号:3197515
-
项目类别:
-
资助金额:$11.25万
-
财政年份:1990
-
负责人:TERRY A BEERMAN
-
依托单位:
EXTRACHROMOSOMAL DNA--A NEW TARGET FOR ANTITUMOR DRUGS
-
批准号:3197513
-
项目类别:
-
资助金额:$10.4万
-
财政年份:1990
-
负责人:TERRY A BEERMAN
-
依托单位:
EXTRACHROMOSOMAL DNA--A NEW TARGET FOR ANTITUMOR DRUGS
-
批准号:3197512
-
项目类别:
-
资助金额:$11.13万
-
财政年份:1990
-
负责人:TERRY A BEERMAN
-
依托单位:
EXTRACHROMOSOMAL DNA--A NEW TARGET FOR ANTITUMOR DRUGS
-
批准号:3197514
-
项目类别:
-
资助金额:$10.84万
-
财政年份:1990
-
负责人:TERRY A BEERMAN
-
依托单位:
MECHANISM OF ACTION OF DNA-REACTIVE ANTITUMOR DRUGS
-
批准号:3168177
-
项目类别:
-
资助金额:$7.28万
-
财政年份:1980
-
负责人:TERRY A BEERMAN
-
依托单位:
MECHANISM OF ACTION OF DNA-REACTIVE ANTITUMOR DRUGS
-
批准号:3168178
-
项目类别:
-
资助金额:$5.2万
-
财政年份:1980
-
负责人:TERRY A BEERMAN
-
依托单位:
MECHANISM OF ACTION OF DNA-REACTIVE ANTITUMOR DRUGS
-
批准号:3168175
-
项目类别:
-
资助金额:$15.45万
-
财政年份:1980
-
负责人:TERRY A BEERMAN
-
依托单位:
MECHANISM OF ACTION OF DNA-REACTIVE ANTITUMOR DRUGS
-
批准号:3168181
-
项目类别:
-
资助金额:$15.54万
-
财政年份:1980
-
负责人:TERRY A BEERMAN
-
依托单位:
海外基金